Abstract:Manganese dioxide (MnO2) nanostructures have aroused great interest among analytical and biological medicine researchers as a unique type of tumor microenvironment (TME)-responsive nanomaterial. However, reliable approaches for synthesizing yolk–shell nanostructures (YSNs) with mesoporous MnO2 shell still remain exciting challenges. Herein, a YSN (size, ∼75 nm) containing a mesoporous MnO2 shell and Er3+-doped upconversion/downconversion nanoparticle (UCNP) core with a large cavity is demonstrated for the first time. This nanostructure not only integrates diverse functional components including MnO2, UCNPs, and YSNs into one system but also endows a size-controllable hollow cavity and thickness-tunable MnO2 layers, which can load various guest molecules like photosensitizers, methylene blue (MB), and the anticancer drugs doxorubicin (DOX). NIR-II fluorescence and photoacoustic (PA) imaging from UCNP and MB, respectively, can monitor the enrichment of the nanomaterials in the tumors for guiding chemo-photodynamic therapy (PDT) in vivo. In the TME, degradation of the mMnO2 shell by H2O2 and GSH not only generates Mn2+ for tumor-specific T1-MR imaging but also releases O2 and drugs for tumor-specific treatment. The result confirmed that imaging-guided enhanced chemo-PDT combination therapy that benefited from the unique structural features of YSNs could substantially improve the therapeutic effectiveness toward malignant tumors compared to monotherapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c08389?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c08389</a>.Experimental details and characterization of nanomaterials; additional TEM, HRTEM, and SEM images and EDS spectra; additional upconversion emission spectra, UV–vis absorption spectra, zeta potentials, and N2 absorption–desorption isotherm; additional relative viabilities, CLSM details, and images; and additional tumor photographs of the treated mice and body weight changes of different groups in the therapeutic period (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c08389/suppl_file/am0c08389_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

A Y(III)-based Metal–Organic Framework as a Carrier in Chemodynamic Therapy

Preparation of nanoscale cationic Metal-Organic Framework Nano Mn(III)-TP for theranostic based on valence changes

Manganese-Zeolitic Imidazolate Frameworks-90 with High Blood Circulation Stability for MRI-Guided Tumor Therapy

Transition Metal (Molybdenum)-Doped Drug-like Conformational Nanoarchitectonics with Altered Valence States (Mn2+/Mn4+ and Mo5+/Mo6+) for Augmented Cancer Theranostics

Iron−Based Metal–Organic Frameworks as Multiple Cascade Synergistic Therapeutic Effect Nano−Drug Delivery Systems for Effective Tumor Elimination

Fabrication of metal-organic framework Mn-PBC for theranostic application

Multifunctional Smart Yolk–Shell Nanostructure with Mesoporous MnO 2 Shell for Enhanced Cancer Therapy

Interfacially Engineered Zn x Mn 1– x S@Polydopamine Hollow Nanospheres for Glutathione Depleting Photothermally Enhanced Chemodynamic Therapy

A Combination of Glioma in Vivo Imaging and in Vivo Drug Delivery by Metal-Organic Framework Based Composite Nanoparticles.

Smart Iron-Based Metal–organic Framework Nanovehicles Gated with CuII-tannic Acid Coordination Polymers for Combination Therapy of Chemotherapy and Chemodynamic Therapy

A multimodal Metal-Organic framework based on unsaturated metal site for enhancing antitumor cytotoxicity through Chemo-Photodynamic therapy

Target Design of Multinary Metal-Organic Frameworks for Near-Infrared Imaging and Chemodynamic Therapy.

Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy

Metal-organic cage as a theranostic nanoplatform for magnetic resonance imaging guided chemodynamic therapy

Multifunctional Smart Yolk-Shell Nanostructure with Mesoporous MnO<sub>2</sub> Shell for Enhanced Cancer Therapy

A Multifunctional Aminated UiO-67 Metal-Organic Framework for Enhancing Antitumor Cytotoxicity Through Bimodal Drug Delivery

Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors

Synthesis and Application of a pH-Responsive Functional Metal–Organic Framework: In Vitro Investigation for Delivery of Oridonin in Cancer Therapy

Fe3O4‐Incorporated Metal‐Organic Framework for Chemo/Ferroptosis Synergistic Anti‐Tumor via the Enhanced Chemodynamic Therapy

Bioactive Metal–Organic Frameworks with Specific Metal–Nitrogen (M–N) Active Sites for Efficient Sonodynamic Tumor Therapy

Hyaluronic acid modified Cu/Mn-doped metal-organic framework nanocatalyst for chemodynamic therapy